4.5 Article

Continuous bioprocessing: The real thing this time? 10th Annual bioProcessUK Conference, December 3-4, 2013, London, UK

Journal

MABS
Volume 6, Issue 6, Pages 1357-1361

Publisher

LANDES BIOSCIENCE
DOI: 10.4161/mabs.36151

Keywords

Biopharmaceutical manufacture; continuous bioprocessing; cell culture; fed-batch; perfusion; continuous chromatography; process economics

Funding

  1. UK Engineering & Physical Sciences Research Council (EPSRC)
  2. Engineering and Physical Sciences Research Council [EP/I033270/1] Funding Source: researchfish
  3. EPSRC [EP/I033270/1] Funding Source: UKRI

Ask authors/readers for more resources

The Annual bioProcessUK Conference has acted as the key networking event for bioprocess scientists and engineers in the UK for the past 10 years. The following article is a report from the sessions that focused on continuous bioprocessing during the 10th Annual bioProcessUK Conference (London, December 2013). These sessions were organized by the 'EPSRC Centre for Innovative Manufacturing in Emergent Macromolecular Therapies' hosted at University College London. A plenary lecture and workshop provided a forum for participants to debate topical issues in roundtable discussions with industry and academic experts from institutions such as Genzyme, Janssen, Novo Nordisk, Pfizer, Merck, GE Healthcare and University College London. The aim of these particular sessions was to understand better the challenges and opportunities for continuous bioprocessing in the bioprocessing sector.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available